Clinical trials
Phase 1/2 Neoplasm Metastasis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2009 | 3 |
| 2014 | 1 |
| 2016 | 5 |
| 2017 | 2 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 7 |
| Active, not recruiting | 7 |
| Terminated | 6 |
| Withdrawn | 1 |
| Unknown status | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| Nuvalent Inc. | 2 |
| University Health Network, Toronto | 2 |
| Array BioPharma | 1 |
| Ascendis Pharma Oncology Division A/S | 1 |
| AstraZeneca | 1 |
| BioNTech SE | 1 |
| Daiichi Sankyo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 31 |
| Colorectal Neoplasms | 6 |
| Triple Negative Breast Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Sarcoma | 5 |
| Stomach Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Renal Cell | 3 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.